In a patient with a complete blood count showing normal white‑blood‑cell count, red‑cell indices, platelet count, and differential but elevated red‑cell distribution width (RDW‑SD and RDW‑CV), what is the clinical significance and what further evaluation and management should be pursued?

Elevated RDW with Normal CBC: Clinical Significance and Management

In a patient with isolated elevation of RDW (both RDW-SD and RDW-CV) but otherwise normal complete blood count parameters, this finding warrants further evaluation for early iron deficiency, nutritional deficiencies, or underlying inflammatory conditions, even in the absence of overt anemia.

Clinical Significance of Isolated Elevated RDW

An elevated RDW reflects increased heterogeneity in red blood cell size (anisocytosis) and serves as an early indicator of iron deficiency before anemia develops 1. In your case:

• RDW-SD: 54.2 fL (elevated)
• RDW-CV: 16.0% (elevated, normal <14-14.5%) 1
• All other CBC parameters including hemoglobin (13.0 g/dL), MCV (92.5 fL), and MCH (28.8 pg) remain normal

Key Pathophysiologic Implications

• Early iron deficiency: RDW increases before MCV decreases, making it a sensitive early marker for iron-restricted erythropoiesis 1. When iron becomes limiting, newly produced red cells are smaller while older cells remain normal-sized, creating the size heterogeneity reflected by elevated RDW 1.

• Mixed deficiency states: Elevated RDW with normal MCV can indicate coexisting microcytic and macrocytic processes that "cancel out" to produce a normal average cell size 1. This occurs when iron deficiency coexists with vitamin B12 or folate deficiency 1.

• Inflammatory conditions: RDW elevation may reflect underlying chronic inflammation, oxidative stress, or metabolic derangement even without anemia 2.

Recommended Evaluation Algorithm

Minimum Initial Workup (First-Line)

The following tests should be obtained immediately 1:

• Serum ferritin - to assess iron stores
• Transferrin saturation (TSAT) - to evaluate iron available for erythropoiesis
• C-reactive protein (CRP) - to identify inflammation that may affect ferritin interpretation
• Reticulocyte count - to assess bone marrow response
• Vitamin B12 and folate levels - to exclude nutritional deficiencies 1

Interpretation Framework

Iron deficiency is likely if 1:

• Ferritin <30 ng/mL (without inflammation)
• TSAT <20%
• Ferritin <100 ng/mL with elevated CRP (functional iron deficiency)

Consider mixed deficiency if 1:

• Normal or low-normal ferritin with elevated RDW
• Macrocytosis indicators present (B12 <200 pg/mL or folate <4 ng/mL)

Extended Workup (If Initial Tests Inconclusive)

Proceed to these additional tests if the cause remains unclear 1:

• Percentage of hypochromic red cells - direct measure of iron-deficient erythropoiesis
• Reticulocyte hemoglobin content - reflects recent iron availability
• Soluble transferrin receptor (sTfR) - elevated in true iron deficiency, helps distinguish from anemia of chronic disease 1
• Haptoglobin and lactate dehydrogenase - to exclude hemolysis 1
• Stool guaiac testing - to identify occult gastrointestinal blood loss 1

Management Approach

If Iron Deficiency Confirmed

Initiate iron supplementation based on the following 1:

• Oral iron trial: 1-3 months of oral iron therapy (ferrous sulfate 325 mg daily or equivalent elemental iron 65 mg) for non-dialysis patients with TSAT ≤30% and ferritin ≤500 ng/mL 1
• Intravenous iron: Consider if oral iron fails, malabsorption suspected, or rapid repletion needed 1
• Investigate source of loss: Evaluate for gastrointestinal bleeding, menstrual losses, or malabsorption 1

If Nutritional Deficiencies Identified

Supplement appropriately 1:

• Vitamin B12 deficiency: Oral or intramuscular B12 supplementation
• Folate deficiency: Oral folic acid 1-5 mg daily 1
• Combined deficiencies: Address all identified deficits simultaneously

Monitoring Strategy

Reassess CBC including RDW after 8-12 weeks of treatment 1:

• Expected response: RDW should normalize as red cell production becomes more uniform
• Persistent elevation despite treatment warrants hematology consultation 1

Important Clinical Caveats

• RDW elevation precedes anemia: Do not wait for hemoglobin to drop before investigating 1. Early intervention prevents progression to overt anemia and associated morbidity.

• Ferritin interpretation requires CRP: Ferritin is an acute phase reactant; inflammation can mask iron deficiency by falsely elevating ferritin levels 1. Use TSAT and sTfR for clarification in inflammatory states.

• Population-specific considerations: RDW reference ranges may vary by age, sex, and ethnicity 1. Your patient's values should be interpreted in appropriate context.

• Prognostic implications: While elevated RDW has been associated with adverse outcomes in cardiovascular disease, chronic kidney disease, and other conditions 2, 3, 4, in your patient with otherwise normal parameters, this likely reflects early nutritional deficiency rather than systemic disease.

• Avoid premature closure: If initial workup is unrevealing and RDW remains elevated, consider consultation with hematology to exclude rare causes such as early myelodysplastic syndrome, hemoglobinopathies, or chronic hemolysis 1.